CD8A and neoplasm: In all experimental groups, NLG919@DEAP-DPPA-1 NPs showed the best inhibitory effect on tumor growth (tumor volume less than 500 mm2 within 14 days) and significantly increased the proportion of CD8+ T cells and cytotoxic T cells producing interferon-γ (IFN-γ) in the tumor tissue.